Mitocurcumin induces ROS-/JNK-mediated paraptosis to overcome chemoresistance in non-small cell lung cancer
Naunyn-Schmiedeberg's Archives of Pharmacology · 2026
DOI: 10.1007/s00210-025-04852-y ↗Kurz gefasst
Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, 2026. Verfasst von Girish Ch Panigrahi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Pharmacology Laboratory, Advanced Centre for Treatment Research and Education in Cancer (ACTREC), Tata Memorial Centre, Navi Mumbai, 410210,…. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Reactive Oxygen Species, Lung Neoplasms, Drug Resistance, Neoplasm. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Department of Atomic Energy, Government of India.
Abstract (Originalsprache)
Lung cancer remains the leading cause of cancer-related mortality worldwide. A major barrier to effective treatment is the development of drug resistance, which contributes to poor patient survival. One key mechanism underlying this resistance is the ability of cancer cells to evade apoptotic cell death. Thus, there is an urgent need for novel therapeutic strategies to overcome chemoresistance in lung cancer. The ultrastructural features of mitochondria and the endoplasmic reticulum (ER) were assessed using transmission electron microscopy (TEM). Transcriptomic profiling of A549 cells was carried out through whole-exome sequencing. Protein expression levels were validated by western blot analysis, while mitochondrial calcium content was quantified using flow cytometry. Our study utilized mitocurcumin (mitoC) to study an alternative form of cell death in NSCLC. Mitochondria and ER vacuolation and swelling were observed upon mitocurcumin treatment. MitoC treatment upregulated ER and mitochondria stress protein levels in A549 and A549R cells. However, the inhibition of intracellular ROS and JNK pathway abrogated mitoC-induced mitochondria and ER stress proteins. Moreover, we observed that mitoC treatment enhanced mitochondrial calcium uptake in A549 and A549R cells, which gets abrogated upon ROS/JNK signaling inhibition. MitoC exerted organellar stress related to paraptosis in A549 and A549R cells through activation of the ROS-mediated JNK signaling pathway and induced mitochondrial calcium uptake.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical Pharmacology Laboratory, Advanced Centre for Treatment Research and Education in Cancer (ACTREC), Tata Memorial Centre, Navi Mumbai, 410210, Maharashtra, India.
- Homi Bhabha National Institute (HBNI), BARC Training School Complex, Anushakti Nagar, Mumbai, 400094, Maharashtra, India.
- Department of Gastroenterology, Hepatology, Infectious Diseases and Endocrinology, Hannover Medical School, Hannover, 30625, Germany.
- Clinical Pharmacology Laboratory, Advanced Centre for Treatment Research and Education in Cancer (ACTREC), Tata Memorial Centre, Navi Mumbai, 410210, Maharashtra, India. vgota76@gmail.com.
- Homi Bhabha National Institute (HBNI), BARC Training School Complex, Anushakti Nagar, Mumbai, 400094, Maharashtra, India. vgota76@gmail.com.
Förderung
- Department of Atomic Energy, Government of India
Zitieren
APA
Panigrahi, G. C., Joshi, A., Malhotra, D., & Gota, V. (2026). Mitocurcumin induces ROS-/JNK-mediated paraptosis to overcome chemoresistance in non-small cell lung cancer. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-025-04852-y
Vancouver
Panigrahi GC, Joshi A, Malhotra D, Gota V. Mitocurcumin induces ROS-/JNK-mediated paraptosis to overcome chemoresistance in non-small cell lung cancer. Naunyn-Schmiedeberg's Archives of Pharmacology. 2026. doi:10.1007/s00210-025-04852-y
BibTeX
@article{Panigrahi2026,
author = {Panigrahi, Girish Ch and Joshi, Amisha and Malhotra, Dinky and Gota, Vikram},
title = {Mitocurcumin induces ROS-/JNK-mediated paraptosis to overcome chemoresistance in non-small cell lung cancer},
journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
year = {2026},
doi = {10.1007/s00210-025-04852-y}
}
EUVIMED